Genentech Submits Application for Venclexta Plus Gazyva for Chronic Lymphocytic Leukemia

Date : 03/07/2019 @ 2:29PM
Source : Dow Jones News
Stock : Roche Holding (QX) (RHHBY)
Quote : 38.03  0.5 (1.33%) @ 9:13PM

Genentech Submits Application for Venclexta Plus Gazyva for Chronic Lymphocytic Leukemia

Roche Holding (QX) (USOTC:RHHBY)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more Roche Holding (QX) Charts.

By Michael Dabaie

 

Roche Holding AG's (RHHBY) Genentech said Thursday it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for Venclexta in combination with Gazyva in people with previously untreated chronic lymphocytic leukemia.

Venclexta is being developed by AbbVie (ABBV) and Genentech.

The FDA is reviewing the application under the Real-Time Oncology Review pilot program, which aims to explore a more efficient review process.

FDA granted breakthrough therapy designation based on results of the randomized Phase III CLL14 study, evaluating the fixed-duration combination of Venclexta plus Gazyva, compared to Gazyva plus chlorambucil, in people with previously untreated CLL and co-existing medical conditions. The study met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

(END) Dow Jones Newswires

March 07, 2019 09:14 ET (14:14 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest RHHBY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.